Engineering and scientific consulting firm Exponent Inc (NASDAQ:EXPO) shares are skyrocketing after the company reported better-than-expected first-quarter FY24 earnings. Exponent reported first-quarter FY24 sales growth of 3.3% year-on-year to $144.93 million, beating the analyst consensus estimate of $125.98 million. Exponent’s engineering and other scientific segment represented 84% of the company’s revenues before reimbursements in the first quarter of 2024. Operating income for the quarter increased 5.5% to $30.7 million, with an operating margin of 21.2%. EPS of $0.59 beat the ...